In the liver, CCR2 is involved in multiple stages of liver pathology, including acute liver injury and chronic hepatitis, fibrosis/cirrhosis, and tumor progression, making it a potential therapeutic target for hepatocellular carcinoma (HCC) (6–8). The gene discussed is CCR2; the disease is chronic hepatitis.